FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Eywa Pharma Inc)

View source ↗

Summary

FDA approved Eywa Pharma Inc's supplemental application for methylphenidate hydrochloride.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)